Characterizing the Immune Environment in Peritoneal Carcinomatosis: Insights for Novel Immunotherapy Strategies
- 23 November 2023
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (3) , 2069-2077
Abstract
Carcinomatosis, a distinct pattern of metastatic cancer in the peritoneal cavity, poses challenges for treatment and has limited therapeutic options. UnderKeywords
Funding Information
- The Glimmer of Hope Foundation
- The Pennsylvania Breast Cancer Coalition
- METAvivor (FP00002718)
- The David Downing Fund
- Cancer Center Support Grant (P30CA047904)
- U.S. Department of War (W81XWH2210009_BC210533, W81XWH2211069_ BC211396)
This publication has 43 references indexed in Scilit:
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentTrends in Immunology, 2016
- Pseudomyxoma Peritonei: Inflammatory Responses in the Peritoneal MicroenvironmentAnnals of Surgical Oncology, 2013
- IL6 trans-signaling promotes functional recovery of hypofunctional phagocytes through STAT3 activation during peritonitisInflammation Research, 2013
- Intraperitoneal Cytokine Level in Patients with Peritoneal Surface Malignancies. A Study of the RENAPE (French Network for Rare Peritoneal Malignancies)Annals of Surgical Oncology, 2013
- Ovarian Cancer Stroma: Pathophysiology and the Roles in Cancer DevelopmentCancers, 2012
- The soluble Interleukin 6 receptor: Generation and role in inflammation and cancerEuropean Journal of Cell Biology, 2011
- Growth factor regulation of proliferation and survival of multipotential stromal cellsStem Cell Research & Therapy, 2010
- Targeting the tumour vasculature: insights from physiological angiogenesisNature Reviews Cancer, 2010
- Pathophysiology and biology of peritoneal carcinomatosisWorld Journal of Gastrointestinal Oncology, 2010
- Normal Human Immune Peritoneal Cells: Subpopulations and Functional CharacteristicsScandinavian Journal of Immunology, 1996